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westeObjective: Clinical practice guidelines have been established for surgical management of the aorta in bicuspid
aortic valve disease. We hypothesized that surgeons’ knowledge of and attitudes toward bicuspid aortic valve
aortopathy influence their surgical approaches.
Methods:We surveyed cardiac surgeons to probe the knowledge of, attitudes toward, and surgical management
of bicuspid aortopathy. A total of 100 Canadian adult cardiac surgeons participated.
Results: Fifty-two percent of surgeons believed that the mechanism underlying aortic dilation in those with
bicuspid aortic valve was due to an inherent genetic abnormality of the aorta, whereas only 2% believed that
altered valve-related processes were involved in this process. Only aminority (15%) believed that bicuspid valve
leaflet fusion type is associated with a unique pattern of aortic dilatation aortic phenotype. Sixty-five percent of
surgeons recommended echocardiographic screening of first-degree relatives of patients with bicuspid aortic
valve.Most surgeons (61%) elected to replace the aortawhen the diameter is 45mmor greater at the time of valve
surgery. Fifty-five percent of surgeons surveyed suggested that in the absence of concomitant valvular disease,
theywould recommend ascending aortic replacement at a threshold of 50mmor greater. Approximately one third
of surgeons suggested that they would elect to replace a mildly dilated ascending aorta (40 mm) at the time of
valve surgery. Themost common surgical approach (61%) for combined valve and aortic surgerywas aortic valve
replacement and supracoronary replacement of the ascending aorta, and only aminority suggested the use of deep
hypothermic circulatory arrest and open distal anastomosis. More aggressive approaches were favored with
greater surgeon experience, and when circulatory arrest was chosen, the majority (68%) suggested they would
use antegrade cerebral perfusion. In the setting of aortic insufficiency and a dilated aorta, 42% of surgeons sug-
gested that they would perform valve-sparing surgery. Of note, 40% of respondents used an index measure of
aortic size to body surface area in addition to absolute aortic diameter in assessing the threshold for intervention.
Conclusions: This large survey uncovered significant gaps in the knowledge and attitudes of surgeons toward
the diagnosis and management of bicuspid aortopathy, many of which were at odds with current guideline rec-
ommendations. Efforts to promote knowledge translation in this area are strongly encouraged. (J Thorac Cardi-
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develop varying degrees of aortic dilatation (referred to as
‘‘bicuspid aortopathy’’).1-9 Three patterns of aortic
dilatation have been suggested, including primary
dilatation of the tubular/mid ascending aorta, involvement
of the distal ascending aorta and proximal arch, and
isolated aortic root dilatation, although no uniform
classification scheme is endorsed.
Accumulating data emphasize that bicuspid aortopathy
exhibits considerable heterogeneity with respect to
molecular, rheological, and clinical characteristics.8,10-13
Controversy exists as to the mechanism through which
bicuspid aortopathy develops. Proponents of the genetic
theory argue that bicuspid aortopathy is due to an
inherent molecular defect in the aorta and develops
independently of valve function, valve morphology, or
hemodynamics.1,11,14-16 On the other hand, emerging data
now point toward a primary hemodynamic basis of
bicuspid aortopathy. Interest in this has been fueled by
recent data that suggest that even a normally functioning
BAV can exhibit abnormal transvalvular flow patterns,
resulting in regional increases in wall shear stress
predicted by the morphologic fusion pattern of the
valve.10,12 The type of fusion pattern may thus dictate the
pattern of aortic dilatation, with a right-left leaflet fusion re-
sulting in flow toward the right anterior wall (potentially re-
sulting in isolated tubular ascending aortic dilatation) and
the right nonleaflet fusion pattern resulting in a flow pattern
toward the posterior aorta leading to arch dilatation.10,12
Aortic aneurysm formation and aortic dissection are the 2
major complications of bicuspid aortopathy. Studies sug-
gest that the rate of growth of ascending aortas is higher
in patients with bicuspid versus tricuspid aortic
valves.5,8,17-24 However, one of the most important
determinants of aortic expansion is the baseline aortic
dimensions (>40mm).25 Although earlier reports suggested
the incidence of aortic dissection to be as high as 5%, recent
data suggest that the incidence is actually lower. In the Tor-
onto series, a rate of 0.1% per patient year follow-up was
noted,26 similar to other recent studies.25,27
There are conflicting reports regarding the fate of the
ascending aorta after AVR.28,29 Although earlier studies
suggested that moderate aortic dilatation (45-49 mm) was
a risk factor for aortic complications after AVR,28 more
recent data from a homogenous population of patients
with aortic stenosis and mild-moderate aortic dilatation
(40-50 mm) revealed that isolated AVR was associated1034 The Journal of Thoracic and Cardiovascular Surwith excellent 10- and 15-year freedom from aortic compli-
cations with no aortic dissection occurring in this cohort
during follow-up.
Guidelines for the management of patients with valvular
heart disease were established in 2006 by the American
College of Cardiology and American Heart Association
(AHA), with a focused update in 2008 that includes recom-
mendations for the surgical management of bicuspid aort-
opathy.30 Elective replacement of the ascending aorta or
aortic root is recommended for patients with BAV when
the aortic diameter is 50 mm or greater whether or not
concomitant valvular or coronary indications are present.
However, the most recent European guidelines recommend
that the aorta be replaced when the aortic root or ascending
aortic diameter is 50 mm or greater in the presence of risk
factors, including coarctation of the aorta, systemic hyper-
tension, family history of dissection, or increase in aortic
diameter of 2 mm or greater per year.31 Although the Euro-
pean guidelines suggest that in other circumstances, surgery
should be delayed until aortic dimensions are 55 mm or
greater, they are in agreement with the American guidelines
that recommend a lower threshold (45 mm) in patients
undergoing AVR.
Although bicuspid aortopathy is a commonly encoun-
tered clinical scenario by the cardiac surgeon, the heteroge-
neous nature of the disease can lead to a variation in the
threshold for aortic replacement. Furthermore, there is no
consensus recommendations as to the extent or type of sur-
gery that such individuals should be subjected to, and no
randomized clinical trials are available to better inform cli-
nicians as to whether an aggressive versus conservative
approach is appropriate. Because the perioperative risk of
complications must be balanced by the actual risk of aortic
complications, it is essential to understand the contempo-
rary knowledge and practice patterns of cardiac surgeons
toward bicuspid aortopathy in an effort to develop knowl-
edge translation platforms for improved clinical care.
MATERIALS AND METHODS
A Bicuspid Aortopathy Working Group (S.V., B.Y., M.R., M.D.P.,
P.W.M.F.) was established and used to develop and validate a questionnaire
to survey cardiac surgeon knowledge and surgical decision-making
regarding the management of patients with bicuspid aortopathy
(Appendix E1). Institutional ethics approval was obtained from St Mi-
chael’s Hospital, University of Toronto, Toronto, Canada. All Canadian
adult cardiac surgeons were invited in person or by e-mail to participate
in the study. Participation was voluntary, and informed consent was pre-
sumed for all participants. We defined an experienced surgeon as one
who performs more than 5 cases per year of complex aortic procedures,
such as valve-sparing aortic root replacement, modified Bentall (composite
graft), and open aortic arch replacement.
RESULTS
Surgeon Demographics
We contacted 142 of the approximately 150 staff adult
cardiac surgeons across Canada. Of these, 8 actively refusedgery c November 2013
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fore yielded a response rate of 70% (100/142) with repre-
sentation from all 10 Canadian provinces (Alberta, British
Columbia, Manitoba, New Brunswick, Newfoundland and
Labrador, Nova Scotia, Ontario, Prince Edward Island,
Quebec, and Saskatchewan) (Figure E1). The response rates
by region were western Canada (50%), central Canada
(73%), and eastern Canada (75%). Our population also
was balanced with respect to years in practice from 0 to 5
to more than 25 years (Figure E2). The median overall
annual case volume was 150 to 200 cases in 50% of sur-
geons (50/100), 200 to 250 cases in 25% of surgeons
(25/100), and 100 to 150 cases in 15% of surgeons
(15/100). Eighty-eight percent of participants described
their practice as academic, and 12% of participants
described their practice as community-based.Knowledge of Bicuspid Aortopathy
Recent experimental and translational studies have pro-
vided evidence for a role of both genetics and hemody-
namics in the pathogenesis of aortic dilation in patients
with BAV.32-37 Our questionnaire demonstrated that 52%
of cardiac surgeons (52/100) believed that the underlying
cause of bicuspid aortopathy was due to genetics, and
40% believed both genetics and hemodynamics play a
role (Figure 1). Only 2% of surgeons (2/100) believed
that hemodynamics alone could be responsible for BAV
aortopathy and progressive aortic dilatation.
Eighty-three percent of surgeons identified themost com-
mon leaflet fusion type as left-right, 6% incorrectly stated
that fusion of the right and noncoronary cusps is the most
common, only 2% selected fusion of the left and noncoro-
nary cusps, and 9% of surgeons admitted that they did not
know the most common fusion pattern. Only a minority of
cardiac surgeons (15% [15/98]) believed that leaflet fusion
type is associated with a unique aortic phenotype, whereas
the majority did not know the answer (58% [57/98]).FIGURE 1. Survey results for primary driver of bicuspid aortopathy.
The Journal of Thoracic and CarFifty-nine percent of surgeons surveyed indicated that
they believed the most common aortic phenotype encoun-
tered in practice was isolated dilation of the ascending
aorta, whereas 30% of respondents indicated that the
most common pattern involved combined aortic root and
ascending aortic dilatation.Preoperative Perspectives
Seventy-three percent of cardiac surgeons (73/100) were
aware of current AHA/American College of Cardiology and
ESC guidelines for the surgical management of BAV.
Awareness of guidelines did not differ significantly between
surgeons in academic compared with community practices
or years in surgical practice (data not shown). In contrast to
the recommendations provided within clinical practice
guidelines, only 65% of cardiac surgeons (65/100) recom-
mended echocardiographic screening of first-degree rela-
tives of patients with BAV (Figure 2). Overall, 97% of
cardiac surgeons (96/99) used preoperative computed to-
mography for determination of maximal aortic dimensions.
We found that 42% of surgeons (42/100) indexed the
maximal aortic dimension to body surface area, 21% of sur-
geons (21/100) indexed to the size of the descending aorta,
9% of surgeons (9/100) indexed to patient height, and 41%
of surgeons (41/100) did not use any size indexing approach
(responses were not mutually exclusive).Surgical Management of the Bicuspid Aorta
A hypothetical 50-year-old male patient with isolated
ascending aortic dilation and a normal functioning BAV
was presented as a case example. Fifty-five percent of sur-
geons (54/99; Figure 3) reported an aortic diameter
threshold for replacement at 50 mm for this patient. In
contrast, 23% of surgeons (23/99) favored a more aggres-
sive approach and recommended replacement of the aorta
at 45 mm. As suggested by the recent European guidelines,
only 19% of surgeons (19/99) responded that they would
not replace the aorta unless 55 mm in size, and 2% of sur-
geons (2/99) recommended a threshold greater than 60 mmFIGURE 2. Survey results of echocardiography for first-degree relatives
of patients with BAV.
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FIGURE 3. Survey results for threshold for replacement of ascending
aorta for a dilated bicuspid ascending aorta. Top: threshold for replacement
of ascending aorta in a 50-year-old patient with BAV that is neither stenotic
nor regurgitant. Bottom: threshold for replacement of ascending aorta in a
50-year-old patient with BAV undergoing surgical AVR.
FIGURE 4. Survey results for threshold for replacement of ascending
aorta for a dilated bicuspid ascending aorta separated by years in practice.
Top: 50 mm and other thresholds for lone replacement of ascending aorta
by years in practice. Bottom: threshold for concomitant replacement of
ascending aorta by years in practice.
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include a stenotic BAV requiring AVR, 61% of surgeons
(61/100; Figure 3) reported a threshold diameter for aortic
replacement at 45 mm. In the setting of AVR, 29% of sur-
geons (29/100) indicated that they would replace the aorta
at 40 mm and 2% of surgeons (2/100) indicated that they
would replace the aorta at 35 mm. Despite the indication
for AVR and at odds with current guidelines, 7% of sur-
geons (7/100) would not replace the aorta unless it was 50
mm or more, and 1% of surgeons (1/100) would not replace
the aorta unless it was 55mm or more. The nature of the sur-
geon’s practice as academic or community-based, the num-
ber of cases performed per year, or awareness of current
guidelines did not influence the threshold for aortic replace-
ment. Surgeons with fewer years in surgical practice tended
toward size thresholds consistent with current guidelines
(Figure 4), perhaps reflecting more recent training and edu-
cation in this area.
We then presented a hypothetical 35-year-old patient
with stenotic BAV, a 53-mm ascending aorta with normal
aortic root and arch dimensions. We found that 61% of sur-
geons (60/99; Figure 5) recommended AVR with supra-
coronary replacement of the ascending aorta. Patient age
did not significantly influence the decision to replace the
aorta.1036 The Journal of Thoracic and Cardiovascular SurThere was a cohort of surgeons whowould perform AVR,
replacement of ascending aorta and hemiarch (15% [15/
99]), Bentall (12% [12/99]), or Bentall and hemiarch
(7% [7/99]). When grouped, this cohort (34% [34/99]) per-
formed more than 10 Bentall procedures (42% [14/33] vs
10% [6/64]) and more than 10 arch replacements with cir-
culatory arrest (33% [10/33] vs 6% [4/64]) per year. In
addition, surgeons in this cohort were more likely to be
referred patients with a dilated root, ascending aorta, and
arch (18% [6/33] vs 2% [1/64]) as the most common pre-
sentation. This cohort did not differ significantly from the
remaining respondents with respect to years in practice,
overall cases per year, academic or community setting,
and aortic replacement thresholds. With respect to knowl-
edge, more surgeons in this cohort believed that an associ-
ation between leaflet fusion configuration and patterns of
aortic dilation exists (24% [8/33] vs 11% [7/62]).
In the case of a patient with mild-moderate aortic insuf-
ficiency secondary to a BAV and an aortic root size of 50
mm with normal ascending and arch dimensions, 41% ofgery c November 2013
FIGURE 5. Survey results of the effect of age on surgical management.
Surgical management for a stenotic BAV with dilated ascending aorta in
35-, 50-, and 75-year-old patients with 53-mm ascending aorta and normal
aortic root and arch. AVR, Aortic valve replacement.
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valve-sparing root replacement (David) procedure. Sur-
geons who perform complex aortic surgeries more
frequently (>5 procedures per year) were more likely to
perform valve-sparing procedures for aortic root dilatation
compared with others (71% [12/17] vs 35% [29/81];
Figure E3).
In regard to intraoperative strategy for hypothermic cir-
culatory arrest to replace the arch/hemi-arch, 58% of sur-
geons (58/100) would cool the patient to 18C to 20C,
28% of surgeons (28/100) would cool the patient to 25C,
and 10% of surgeons (10/100) would cool the patient to
28C to 30C. Also, 68% of surgeons (68/100) would use
selective antegrade perfusion for cerebral protection, 9%
of surgeons (9/100) would use selective retrograde, and
22% of surgeons (22/100) would not use any type of cere-
bral perfusion.
DISCUSSION
In this report, we probed cardiac surgeon knowledge of,
attitudes toward, and approaches to the surgical manage-
ment of bicuspid aortopathy. Our data highlight a significant
variability in practice patterns and disparity between guide-
lines and proposed strategies for bicuspid aortopathy. The
majority of cardiac surgeons were knowledgeable of BAV
aortopathy, leaflet fusion patterns, and predisposition to
aortic dilation. Few surgeons acknowledged an association
between leaflet fusion configuration and pattern of aorticThe Journal of Thoracic and Cardilatation—an emerging theme in bicuspid aortopathy.10,12
Surgeons strongly favored genetics over hemodynamics as
the underlying mechanism for bicuspid aortopathy.
However, the relative contribution of genetics or an
inherited aortopathy compared with acquired effects of
altered blood flow and wall stresses from the abnormal
valve remains unclear. Although theories supporting an
inherited aortopathy have been popular, more recent data
support a critical role of hemodynamic influences.11 BAV
is a heterogeneous condition with different anatomic and
clinical phenotypes.38 Phenotypic classification is some-
what challenged by the referral bias to surgeons and to aortic
surgeons in particular, who may see more patients with arch
or root dilatation. The emergence of specialized clinics for
patients with BAV may be capable of registering patients
with BAV before surgery and may shed light on phenotypes
and their progression to requiring surgical interventions.
Further research to correlate tissue changes with regional
hemodynamic stresses may shed light on the cellular and
molecular mechanisms of this elusive clinical condition.
As reviewed by Verma and Fedak,14 elegant work by Ikono-
midis and colleagues15,16 has demonstrated a unique
fingerprint of bicuspid aortopathy correlating leaflet fusion
morphology with the extent of aortic dilatation.
A significant number of cardiac surgeons do not support
echocardiographic screening of first-degree relatives, which
is indicated in the 2010 American College of Cardiology
Foundation/AHA/American Association for Thoracic Sur-
gery/American College of Radiology/American Stroke As-
sociation/Society of Cardiovascular Anesthesiologists/
Society for Cardiovascular Angiography and Interven-
tions/Society of Interventional Radiology/Society of
Thoracic Surgeons/Society for Vascular Medicine guide-
lines.39 Studies have documented an increased prevalence
of BAV in first-degree relatives, supporting a hereditary
component for BAV.40,41 An echocardiographic study of
30 families with BAV found that 37% of families had
more than 1 affected first-degree relative.41 This is a clear
opportunity to identify a vulnerable population and should
be a focus for knowledge dissemination efforts. Enrollment
of patients with BAV into specialized valve clinics may in-
crease the screening efforts and improved adherence to cur-
rent guidelines.
Although the majority of surgeons follow recommended
aortic size thresholds for replacement of the ascending
aorta, it was notable that those who had been more recently
trained made choices more consistent with the guidelines,
suggesting greater familiarity with recent guidelines. How-
ever, other surgeons are considerably more aggressive or
conservative in their approach. It was surprising that some
surgeons advocated resection of the aorta with normal di-
mensions and no indication of dilatation. Although
concomitant replacement likely adds only a small incre-
mental operative risk, such an aggressive approach is notdiovascular Surgery c Volume 146, Number 5 1037
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concomitant procedures require further investigation. In
contrast, others treated patients with BAV as they would
any other patient with aortic dilatation, perhaps reflecting
a lack of knowledge of current recommendations and the
threat of BAV aortopathy. The strength of the evidence
used in the development of the current guidelines may be
questionable, resulting in variable surgeon practices and
poor adherence to expert recommendations. The surgical
guidelines for the bicuspid aorta recommend thresholds
for aortic replacement primarily on the basis of nonrandom-
ized data and expert opinion. The current observations sug-
gest that a randomized control trial of surgical intervention
(at a specific aortic threshold) versus watchful waiting
should be considered. For now, therefore, it would seem
that continuing medical education efforts focused on appro-
priate management of patients with BAV with aortopathy
should be considered.
After the decision to replace the aorta, there is a wide
variation in the extent and type of aortic repair used. The
majority of surgeons supported a conservative approach to
both aortic root and aortic arch replacement at the time of
ascending aorta replacement. Among surgeons who more
frequently perform complex aortic procedures, the optimal
surgical approach differed widely but generally favored a
more aggressive extent of aortic resection. These surgeons
presumably are more aggressive in an attempt to prevent
future complications or reoperations, and perhaps their
increased experience with complex aortic procedures jus-
tifies this approach by a low operative morbidity and mor-
tality. In selected patients, a complex root or arch
intervention in experienced hands has a low incremental
surgical risk, and such an approach may be rational. For
example, a single-center series of 206 patients with BAV
stenosis and aortic aneurysm underwent a Bentall procedure
with low surgical mortality (2.9%) and no short-term reop-
erations for aortic complications.42 However, even in this
series, the surgical approach varied widely for Bentall,
hemi-arch, or some combination. This suggests that the
optimal strategy is yet unidentified and highlights an unmet
need in terms of surgical management.
A less aggressive approach, despite the ability to perform
complex procedures with a low risk, may be warranted. The
rationale for replacement of the dilated aorta is to prevent
dissection, aneurysm formation, aortic rupture, and sudden
cardiac death.McKellar and colleagues43 reviewed 1286 pa-
tients with BAVat theMayo Clinic who underwent AVR and
found 89% 15-year freedom from aortic dissection, aortic
replacement, or aortic dilatation. Multivariable predictors
included repeat AVR, concomitant coronary artery bypass
grafting, smoking, and aortic enlargement at the time of
operation. Girdauskas and colleagues29 followed 153 pa-
tients with BAVand 40- to 50-mm ascending aortas who un-
derwent AVR. They reported a 93% 15-year freedom from1038 The Journal of Thoracic and Cardiovascular Suradverse aortic events, including 3% aortic replacement and
no incidence of dissection. A recent long-term follow-up
study demonstrated that aortic dissection occurred in only
2 of 416 patients with BAVover a mean follow-up of 16 
7 years, an incidence of 3.1 cases per 10,000 patient years
with no dissections with aortic diameter less than 45 mm
or normal functioning aortic valves.25 Some surgeons advo-
cate for aggressive resection of the distal aorta and perform
an ‘‘open distal’’ using short periods of circulatory arrest in
an effort to resect as much aorta as possible. More recent
data do not support this practice.44 A less aggressive
approach as described in this study by surgeons who would
not replace a concomitant dilated aorta until 50 or 55 mm
may put the patient at risk of future aortic complications
or interventions.28 There were no differences between prac-
tice settings, but surgeons who were in earlier years of prac-
tice tended to adhere closer to current guidelines.
Although the guideline recommendations are largely
based on aortic root or ascending aortic diameter thresholds,
it was noteworthy that 63% of respondents indicated that in
addition to these absolute measurements they would
consider alternative indices of aortic size (aortic diameter
indexed to body surface area or ratio of ascending to de-
scending diameter) in decision-making.
Study Limitations
These data represent the results of voluntary participation
and may not be reflective of the entire cardiac surgeon pop-
ulation, particularly outside of Canada where practice
patterns may differ. Answers were not verified for accuracy.
We were unable to determine the rationale behind the
cardiac surgeons’ decision-making. Our surgical scenarios
were rather simple, and the surgical decision-making for in-
dividual patients is in reality more complex. We did not
consider other factors, such as patient preference for a bio-
prosthetic or mechanical valve, symptoms, comorbidities,
or other factors that determine the decision to perform
surgery and the type of repair performed. We did not specif-
ically ask whether the surgeons’ approach to bicuspid
aortopathy would change if coincident replacement of the
aortic valve was performed with a mechanical versus tissue
prosthesis. It is possible that surgeons would be more
aggressive at addressing the aorta when implanting a
mechanical versus tissue valve. Finally, we did not ask
surgeons about their recommendations regarding antihyper-
tensive therapies, exercise prescription, and management of
bicuspid aortopathy in pregnancy, which are all important
clinical questions.
CONCLUSIONS
Through a survey of 100 Canadian cardiac surgeons, we
determined that the majority were knowledgeable of
bicuspid aortopathy and the current guidelines regarding
its surgical management. Seemingly at odds with thesegery c November 2013
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was highly variable, particularly in size thresholds for aortic
replacement and the type and extent of surgical repair for
the aortic root and arch. To our surprise, approximately
one third of surveyed cardiac surgeons would replace the
ascending aorta at a threshold of 40 mm in patients with
BAV. Emerging data suggest that the actual rates of aortic
dissection are lower than previously believed, and that
only unique phenotypes (eg, the root phenotype) may be
at so-called higher risk. Thus, it is imperative that surgeons
be educated about the natural history of bicuspid aortopathy
and the types of dilatation that are more likely to progress to
ensure that an exceedingly aggressive approach is not adop-
ted unless necessary. There is an urgent need for a bio-
markers of aortic progression (biochemical or rheological)
to help better define, within this heterogeneous population,
the individuals with bicuspid aortopathy in whom aggres-
sive intervention should be begun. The highly variable sur-
gical approaches and departures from current guidelines
represent potential gaps in knowledge translation and the
need for evidence-based decision-making for this popula-
tion of patients.
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(Version 1.1)
Question 1: How many years have you been in practice
as a staff cardiac surgeon? (Check one)
, A: 0-5 years
, B: 5-10 years
, C: 10-15 years
, D: 15-20 years
, E: 20-25 years
, F:>25 years
Question 2: How would you describe your cardiac sur-
gical practice? (Check one)
, A: Academic setting
, B: Community setting
Question 3: In what province is your cardiac surgical
practice? (Check one)
, A: British Columbia
, B: Alberta
, C: Saskatchewan
, D: Manitoba
, E: Ontario
, F: Quebec
, G: Nova Scotia
, H: New Brunswick
, I: Newfoundland
Question 4: How many cardiac cases do you perform
per year? (Check one)
, A: 0-50
, B: 50-100
, C: 100-150
, D: 150-200
, E: 200-250
, F:>250
Question 5: What is the proportion of aortic valve re-
placements/repairs that you perform each year?
(Check one)
, A: 1%-10%
, B: 10%-20%
, C: 20%-30%
, D:>40%
Question 6: Approximately how many of the following
procedures do you perform per year in your current
practice? (Check one)
I Ascending aortic replacements (supracoronary graft,
closed distal), A: None
, B: 0-5 cases
, C: 5-10 casesThe Journal of Thoracic and Cardiova, D: 10-20
, E:>20
II Bentall procedure
, A: None
, B: 0-5 cases
, C: 5-10 cases
, D: 10-20 cases
, E:>20 cases
III Hemiarch and arch replacements with circulatory
arrest
, A: None
, B: 0-5 cases
, C: 5-10 cases
, D:>10 cases
IV Aortic valve repair (valve-sparing operation)
, A: None
, B: 0-5 cases
, C: 5-10 cases
, D:>10 cases
Question 7: Do you think that aortic dilation associated
with bicuspid aortic valve is a unique pathological
condition? (Check one)
, A: Yes
, B: No
, C: Don’t know
Question 8: In your opinion, what is the primary driver
of bicuspid aortopathy? (Check one)
, A: Genetics
, B: Hemodynamics
, C: Both
, D: Don’t know
Question 9: In your practice, what is the most common
form of aortic dilatation that you see in patients with
bicuspid aortic valve? (Check one)
, A: Dilation of the ascending aorta only
, B: Dilation of the aortic root only
, C: Dilation of the transverse aorta only
, D: Dilation of the ascending aorta and aortic root
, E: Dilation of the ascending aorta and transverse
aortic arch
, F: Dilation of the aortic root, ascending aorta and
transverse aortic arch
, G: Don’t know
Question 10: In your opinion, what is the most common
type of leaflet fusion pattern associated with
bicuspid aortic valve? (Check one)
, A: Left-Right
, B: Left-Nonscular Surgery c Volume 146, Number 5 1040.e1
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, D: Don’t know
Question 11: In your opinion, is the type of leaflet
fusion pattern associated with a unique aortic dila-
tion phenotype? (Check one)
, A: Yes
, B: No
, C: Don’t know
Question 12: Consider a 50-year-old patient with
bicuspid aortic valve that is neither stenotic nor re-
gurgitant. In your practice, what is your size
threshold to replace the ascending aorta? (Check
one)
, A: 35 mm
, B: 40 mm
, C: 45 mm
, D: 50 mm
, E: 55 mm
, F: 60 mm
, G: Don’t know
Question 13: Consider a 50-year-old patient with
bicuspid aortic valve undergoing aortic valve replace-
ment for aortic stenosis. In your practice, what is your
size threshold to replace the ascending aorta? (Check
one)
, A: 35 mm
, B: 40 mm
, C: 45 mm
, D: 50 mm
, E: 55 mm
, F: 60 mm
, G: Don’t know
Question 14: You are performing aortic valve replace-
ment on a 35-year-old patient with bicuspid aortic
stenosis. The ascending aorta is 53 mm and the
root and arch are normal. What operation would
you perform? (Check one)
, A: AVR only
, B: AVR and replacement of ascending aorta (cross-
clamp on)
, C: AVR and aortoplasty
, D: AVR, replacement of ascending aorta and hemi-
arch (open distal anastomosis)
, E: Bentall
, F: Bentall and hemiarch
, G: Aortic valve sparing procedure
, H: Aortic valve sparing procedure and hemiarch
, I: Replacement of ascending aorta and hemiarch
, J: Don’t know40.e2 The Journal of Thoracic and Cardiovascular Surger14a: If the aforementioned patient was aged 50 years,
which of the following would you perform?
(Check one)
, A: AVR only
, B: AVR and replacement of ascending aorta
(crossclamp on)
, C: AVR and aortoplasty
, D: AVR, replacement of ascending aorta and
hemiarch (open distal anastomosis)
, E: Bentall
, F: Bentall and hemiarch
, G: Aortic valve sparing procedure
, H: Aortic valve sparing procedure and
hemiarch
, I: Replacement of ascending aorta and hemiarch
, J: Don’t know
14b: If the aforementioned patient was aged 75 years,
which of the following would you perform?
(Check one)
, A: AVR only
, B: AVR and replacement of ascending aorta (with
crossclamp)
, C: AVR and aortoplasty
, D: AVR, replacement of ascending aorta and
hemiarch (open distal anastomosis)
, E: Bentall
, F: Bentall and hemiarch
, G: Aortic valve sparing procedure
, H: Aortic valve sparing procedure and hemiarch
, I: Replacement of ascending aorta and hemiarch
, J: Don’t know
Question 15: In a patient with mild-moderate aortic
insufficiency secondary to a bicuspid aortic valve
and a aortic root of 50 mm, with a normal
ascending aorta and normal aortic arch, would
you perform a valve sparing root replacement?
(Check one)
, A: Yes
, B: No
, C: Don’t know
Question 16: In patients with a bicuspid aortic valve
when replacing the ascending aorta electively how
often do you perform an open distal anastomosis?
(Check one)
, A: Never
, B: 0%-25%
, C: 25%-50%
, D: 50%-75%
, E:<75%y c November 2013
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what cerebral protection strategy would you use
during deep hypothermic circulatory arrest?
(Check one)
, A: Antegrade selective cerebral perfusion
, B: Retrograde selective cerebral perfusion
, C: No cerebral perfusion
, D: Don’t know
, E: Not applicable
16b: If you are planning on performing an open
distal anastomosis or limited hemiarch with circu-
latory arrest, to what temperature do you cool the
patient? (Check one)
, A: 18C-20C
, B: 25C
, C: 28C-30C
, D: 32C
, E: 34C
, F: Not applicable
Question 17: In your practice what modality do you use
to best assess the size of the ascending aorta? (Check
one)
, A: Echocardiography
, B: Computed tomography
, C: Magnetic resonance imagingFIGURE E1. Cardiac surgeon demographics. Region of practice.
The Journal of Thoracic and CardioQuestion 18: In your practice which of the following
alternative measures of aortic size do you employ?
(Check all that apply)
, A: Ratio of ascending aorta to descending aorta
, B: Ascending aorta indexed to body surface area
, C: Ascending aorta indexed to patient height
, D: I do not use other measures
, E: Other_________________________
Question 19: In your practice, do you recommend that
first degree relatives of patients with bicuspid aortic
valve undergo echocardiographic screening? (Check
one)
, A: Yes
, B: No
, C: Don’t know
Question 20: Are you aware of the current AHA/ESC
guidelines regarding the management of the
ascending aorta in patients with bicuspid aortic
valves? (Check one)
, A: Yes
, B: No
AHA, American Heart Association; AVR, aortic valve
replacement; ESC, European Society of Cardiology.FIGURE E2. Cardiac surgeon demographics. A, Years in practice. B,
Average number of cases performed per year.
vascular Surgery c Volume 146, Number 5 1040.e3
FIGURE E3. Cardiac surgeon demographics. Top: Proportion of Bentall
procedures by surgeons who perform 0 to 5 versus more than 5 Bentall pro-
cedures per year.Middle: Proportion of aortic arch replacement procedures
by surgeons who perform 0 to 5 versus more than 5 aortic arch replacement
procedures per year. Bottom: Proportion of valve-sparing root replacement
procedures by surgeons who perform 0 to 5 versus more than 5 valve-
sparing root replacement procedures per year.
Cardiothoracic Surgical Education and Training Verma et al
1040.e4 The Journal of Thoracic and Cardiovascular Surgery c November 2013
E
D
U
